Cargando…
Phase 1 Study to Evaluate the Safety of Reducing the Prophylactic Dose of Dexamethasone around Docetaxel Infusion in Patients with Prostate and Breast Cancer
SIMPLE SUMMARY: Docetaxel has been approved as an anti-cancer agent in 1995. High rates of hypersensitivity reactions (HSR) and fluid retention were observed when this agent was first introduced. The use of high dose systemic corticosteroids around docetaxel infusion appeared to decrease the inciden...
Autores principales: | Lugtenberg, Rieneke T., de Groot, Stefanie, Houtsma, Danny, Dezentjé, Vincent O., Vulink, Annelie J. E., Fischer, Maarten J., Portielje, Johanneke E. A., van der Hoeven, Jacobus J. M., Gelderblom, Hans, Pijl, Hanno, Kroep, Judith R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046524/ https://www.ncbi.nlm.nih.gov/pubmed/36980577 http://dx.doi.org/10.3390/cancers15061691 |
Ejemplares similares
-
Effects of short-term fasting on cancer treatment
por: de Groot, Stefanie, et al.
Publicado: (2019) -
Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy
por: de Groot, Stefanie, et al.
Publicado: (2017) -
Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013–14) trial
por: Lugtenberg, Rieneke T., et al.
Publicado: (2020) -
Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia — a randomized controlled trial
por: Lugtenberg, Rieneke T., et al.
Publicado: (2022) -
Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma
por: de Groot, Stefanie, et al.
Publicado: (2020)